{"id":"ipv-id-needle","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions (erythema, induration)"},{"rate":null,"effect":"Pain at injection site"}]},"_chembl":{"chemblId":"CHEMBL2108443","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The device delivers IPV intradermally rather than intramuscularly, targeting the rich immune cell populations in the skin to potentially enhance immune response while reducing vaccine volume requirements. This needle-based intradermal approach aims to improve vaccination efficiency and reduce the overall antigen dose needed for protective immunity against poliovirus.","oneSentence":"IPV ID Needle is an intradermal delivery device designed to administer inactivated polio vaccine (IPV) using a micro-needle approach for improved immunogenicity and patient compliance.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:50:11.959Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Poliomyelitis prevention (intradermal administration of IPV)"}]},"trialDetails":[{"nctId":"NCT02967783","phase":"NA","title":"A Campaign-based ID fIPV Administration Trial","status":"COMPLETED","sponsor":"Medical Research Council Unit, The Gambia","startDate":"2017-02-07","conditions":"Poliomyelitis","enrollment":2721},{"nctId":"NCT01847872","phase":"PHASE4","title":"IPV Clinical Trial - The Gambia","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-07","conditions":"Poliomyelitis","enrollment":1504},{"nctId":"NCT02769923","phase":"NA","title":"ID Administration of fIPV Using Intradermal Adapters vs. BCG Syringe","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2015-09","conditions":"IPV","enrollment":450}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Inactivated Poliovirus Vaccine Intradermal using syringe and needle pair"],"phase":"marketed","status":"active","brandName":"IPV ID Needle","genericName":"IPV ID Needle","companyName":"London School of Hygiene and Tropical Medicine","companyId":"london-school-of-hygiene-and-tropical-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IPV ID Needle is an intradermal delivery device designed to administer inactivated polio vaccine (IPV) using a micro-needle approach for improved immunogenicity and patient compliance. Used for Poliomyelitis prevention (intradermal administration of IPV).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}